GT
62
6
UA
50
-9
LLY
37
-3
NRG
49
-3
NKE
36
6
PYPL
54
2
FLR
58
3
TROW
56
5
DTE
56
2
EMN
60
4
PLD
56
8
DOW
44
10
COF
60
2
HP
48
3
DHI
48
4
INTC
33
-2
URBN
56
14
APD
59
2
LEG
36
4
CVX
47
3
GT
62
6
UA
50
-9
LLY
37
-3
NRG
49
-3
NKE
36
6
PYPL
54
2
FLR
58
3
TROW
56
5
DTE
56
2
EMN
60
4
PLD
56
8
DOW
44
10
COF
60
2
HP
48
3
DHI
48
4
INTC
33
-2
URBN
56
14
APD
59
2
LEG
36
4
CVX
47
3
Financhill
Back

Autolus Therapeutics PLC 10K Form

Buy
53

AUTL
Autolus Therapeutics PLC

Last Price:
2.95
Seasonality Move:
-10.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $1.7M
Cash Flow: $-86.33M
Price / Cash Flow: 0
Annual Sales: $1.79
Price / Book: 1.64

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-270.23M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 7,684.39% of Revenue.
  • The Interest Expense is -21.63% of Operating Income.
  • The Net Earning history of AUTL is -12,272.26% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Buy
53
Autolus Therapeutics PLC (AUTL) is a Buy

Is Autolus Therapeutics PLC a Buy or a Sell?